Approval · Notice of Compliance 16876 · 2015
FERAHEME: Notice of Compliance 16876
Issued April 21, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16876
- Date
- April 21, 2015
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in drug substance manufacturing proces: chane in the ultrafiltration purification membrane fro spiral to flat configuration
- Therapeutic class
- Hematinic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FERAHEME | Not yet assigned | — |
Medicinal ingredients
- FERUMOXYTOL 30 MG per ML